Home > Boards > US Listed > Miscellaneous > TherapeuticsMD, Inc. (TXMD)

Continuos failure after years of pumping. This Company

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JCB5 Member Profile
 
Followed By 46
Posts 5,469
Boards Moderated 0
Alias Born 04/16/08
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/21/2020 9:29:31 AM
TherapeuticsMD, an Innovative Women’s Healthcare Company, & PlushCare, a Virtual Health Platform, Announce Enhanced Access ... Business Wire - 1/7/2020 6:30:00 AM
TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access ... PR Newswire (US) - 1/7/2020 6:30:00 AM
TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference Business Wire - 1/6/2020 6:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/30/2019 7:03:50 AM
TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners Business Wire - 12/30/2019 6:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2019 5:28:52 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/10/2019 2:55:19 PM
Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada Business Wire - 11/26/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 6:48:08 AM
TherapeuticsMD Announces Participation at the Stifel 2019 Healthcare Conference Business Wire - 11/12/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2019 4:19:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 4:11:23 PM
TherapeuticsMD Announces Third Quarter 2019 Financial Results Business Wire - 11/6/2019 4:05:00 PM
TherapeuticsMD to Report Third Quarter 2019 Results on November 6, 2019 Business Wire - 11/1/2019 4:05:00 PM
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada Business Wire - 10/30/2019 5:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/29/2019 5:18:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/29/2019 5:17:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/29/2019 5:16:01 PM
TherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock Business Wire - 10/29/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2019 8:53:18 AM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 10/25/2019 4:48:17 PM
TherapeuticsMD Announces Pricing of Its Underwritten Public Offering of 26 Million Shares of Common Stock Business Wire - 10/24/2019 7:46:00 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 10/24/2019 6:03:51 AM
JCB5   Wednesday, 12/27/17 09:26:24 AM
Re: None
Post # of 429 
Continuos failure after years of pumping. This Company is still taking investors money for multi million dollar salaries. Looks like the shorts own this and paid analyst are losing credibility. SELL ALERT.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist